Literature DB >> 48661

Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.

M Biniaminov, B Ramot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48661     DOI: 10.1016/s0140-6736(75)91543-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

Authors:  C Moroz; N Lahat; M Biniaminov; B Ramot
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

2.  The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.

Authors:  H Verhaegen; W De Cock; J De Cree
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Levamisole as an immunotherapeutic agent in the treatment of cancer.

Authors:  W K Amery
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

4.  Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.

Authors: 
Journal:  Br Med J       Date:  1975-08-23

5.  Defective neutrophil chemotaxis and raised serum ige levels in a child with recurrent bacterial infections and eczema. Influence of levamisole.

Authors:  J De Cree; L Emmery; J Timmermans; R Eeckels; W De Cock; H Verhaegen
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

6.  Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.

Authors:  W De Cock; J De Cree; H Verhaegen
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

7.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

8.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

9.  Whipple's disease in a female with impaired cell-mediated immunity unresponsive to co-trimoxazole and levamisole therapy.

Authors:  M R Haeney; I N Ross
Journal:  Postgrad Med J       Date:  1978-01       Impact factor: 2.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.